Portage Biotech
PRTG
#10231
Rank
โ‚น1.40 B
Marketcap
Country
โ‚น615.78
Share price
-2.16%
Change (1 day)
90.46%
Change (1 year)

Portage Biotech (PRTG) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : โ‚น0.27 Billion

According to Portage Biotech's latest financial reports the company's total liabilities are โ‚น0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Portage Biotech - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2025-03-31โ‚น0.26 B-29.69%
2024-03-31โ‚น0.37 B-80.97%
2023-03-31โ‚น1.94 B-12.12%
2022-03-31โ‚น2.21 B11.19%
2021-03-31โ‚น1.99 B-3.79%
2020-03-31โ‚น2.07 B18.73%
2019-03-31โ‚น1.74 B6886.74%
2018-03-31โ‚น25 M24.34%
2017-03-31โ‚น20.1 M1.26%
2016-03-31โ‚น19.85 M-48.64%
2015-03-31โ‚น38.66 M235.74%
2014-03-31โ‚น11.51 M-52.52%
2013-03-31โ‚น24.25 M-82.08%
2012-03-31โ‚น0.13 B345.95%
2011-03-31โ‚น30.34 M-80.59%
2010-03-31โ‚น0.15 B2469.13%
2009-03-31โ‚น6.08 M164.79%
2008-03-31โ‚น2.29 M26.73%
2007-03-31โ‚น1.81 M-71.42%
2006-03-31โ‚น6.34 M41.96%
2005-03-31โ‚น4.46 M-84.4%
2004-03-31โ‚น28.65 M157.7%
2003-03-31โ‚น11.11 M80.1%
2002-03-31โ‚น6.17 M39.9%
2001-03-31โ‚น4.41 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
โ‚น10.97 B 3,877.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น0.28 B 3.15% Bahamas